Can Methotrexate Cause Mouth Sores?
Yes, methotrexate commonly causes oral mucositis (mouth sores), which is one of the most frequently reported adverse reactions to this medication. 1
Incidence and Clinical Presentation
Oral mucositis is a well-established side effect of methotrexate across all indications and dosing regimens:
- Ulcerative stomatitis is listed among the most frequently reported adverse reactions in the FDA drug label 1
- In rheumatoid arthritis patients on low-dose methotrexate, oral ulcers occur in approximately 6.2% of patients, with 30% reporting previous episodes 2
- In pediatric cancer patients receiving high-dose methotrexate, oral mucositis develops in 74.9% of treatment cycles, with nearly half (46.6%) presenting with ulcerative lesions 3
Types of Methotrexate-Induced Oral Lesions
The clinical presentation varies and can be stratified into distinct patterns 2:
- Deep irregular ulcers (44.9% of cases)
- Aphthous-like ulcers (30.6% of cases)
- Diffuse mucositis (14.3% of cases)
- Lichenoid reactions (10.2% of cases)
Mechanism and Risk Factors
Methotrexate causes mouth sores through its inhibition of rapidly dividing cells in the oral mucosa 1. Several factors increase risk:
- Lack of folic acid supplementation - This is a critical modifiable risk factor 4
- Higher methotrexate doses and longer treatment duration correlate with more severe and generalized oral ulceration 2
- Delayed methotrexate clearance and elevated 42-hour methotrexate levels 5
- Concurrent fever, skin rashes, and neutropenia are independent predictors of mucositis 5
- Renal and hepatic toxicity serve as risk factors, particularly in lymphoma patients 3
Prevention and Management
Folic acid supplementation is strongly recommended for all patients taking methotrexate to reduce mucosal and gastrointestinal side effects 4:
- Standard dosing is 1 mg daily, given on all days except the day methotrexate is taken 4
- Doses can be escalated up to 5 mg daily if gastrointestinal side effects or early toxicity develop 4
- The British Association of Dermatologists provides Grade A evidence (strength of recommendation A, level of evidence 1++) supporting routine folic acid supplementation 4
Patients should be counseled to seek urgent medical attention if they develop mouth ulceration, as this may indicate methotrexate toxicity requiring dose adjustment or temporary discontinuation 4.
Dose Modifications for Intolerance
When oral methotrexate causes intolerable side effects including stomatitis 4:
- Split dosing over 24 hours or switching to subcutaneous administration is conditionally recommended over switching to alternative medications 4
- Increasing folic acid dosage should be attempted before abandoning methotrexate therapy 4
- These strategies are preferred because of methotrexate's proven efficacy, long-term safety profile, and low cost 4
Critical Warning
The FDA label explicitly warns patients to seek urgent medical attention for mouth ulceration as a sign of potential bone marrow suppression or methotrexate toxicity 4. This is particularly important as medication errors (such as daily instead of weekly dosing) can cause severe, life-threatening mucositis 6.